Kern D H, Chien F W, Goodwein S N, Sondak V K
Surgical Service, Veterans Administration Medical Center, Sepulveda, California 91343.
In Vitro Cell Dev Biol. 1987 Dec;23(12):863-6. doi: 10.1007/BF02620966.
Because low plating efficiencies of most human cancers severely limit the number of successful chemosensitivity tests that can be performed, we studied the growth-enhancing effects of hormonal growth factors on a variety of solid tumors. Dose-response studies with progesterone and estradiol indicated no benefit from adding these substances to the culture medium. This was true whether progesterone or estradiol was used alone or in the presence of other hormones. By contrast, epidermal growth factor (EGF) at concentrations from 10 to 100 ng/ml increased colony numbers up to 10-fold. Although insulin, hydrocortisone, and EGF used alone could either stimulate or inhibit the growth of specific tumors, the combination of all three (hormone mixture or HM) was always at least as good and usually better than any individual component in increasing cloning efficiency. HM-supplemented medium gave significantly increased colony counts in 41/46 tumors. Sensitivity to anticancer drugs was not changed in 63 paired drug tests.
由于大多数人类癌症的低接种效率严重限制了能够进行的成功化学敏感性测试的数量,我们研究了激素生长因子对多种实体瘤的生长促进作用。用孕酮和雌二醇进行的剂量反应研究表明,向培养基中添加这些物质并无益处。无论孕酮或雌二醇单独使用还是与其他激素一起使用,都是如此。相比之下,浓度为10至100 ng/ml的表皮生长因子(EGF)可使集落数量增加多达10倍。尽管单独使用胰岛素、氢化可的松和EGF可以刺激或抑制特定肿瘤的生长,但在提高克隆效率方面,这三种物质的组合(激素混合物或HM)总是至少与任何单一成分一样好,而且通常更好。添加HM的培养基在46个肿瘤中有41个的集落计数显著增加。在63次配对药物测试中,对抗癌药物敏感性没有变化。